Psyence Biomedical Ownership | Who Owns Psyence Biomedical?

Psyence Biomedical Ownership Summary

Psyence Biomedical is owned by 103.98% institutional investors, 0.59% insiders.

PBM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Psyence Biomedical	103.98%	0.59%	-4.57%
Sector	Healthcare Stocks	278.70%	10.61%	-189.31%
Industry	Biotech Stocks	63.84%	10.66%	25.50%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	11	10.00%	2,014,160	122.21%	103	4.75%	8	60.00%	1	-50.00%
Jun 30, 2024	10	-	906,418	22.31%	46	3.20%	5	-50.00%	2	-
Mar 31, 2024	10	-	741,092	-	38	-	10	-	-	-

PBM Ownership FAQ

Who Owns Psyence Biomedical?

Psyence Biomedical shareholders are primarily institutional investors at 103.98%, followed by 0.59% insiders and -4.57% retail investors. The average institutional ownership in Psyence Biomedical's industry, Biotech Stocks , is 63.84%, which Psyence Biomedical exceeds.

Does Blackrock own Psyence Biomedical?

BlackRock is not among the top 10 institutional shareholders of Psyence Biomedical.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools